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Non assembled
Stimuli
-pH
-Temperature
-Ionic Strength
-Specific enzymes
Self-
assembly
Rational Design of Antimicrobial 
Peptide Motif vs Self-assembly
Antimicrobial Activity Propensity to Self‐assembled hydrogels
Hydrophobic/Hydrophilic (Charge) ratio 
(more important with regard to antimicrobial 
activity than size)
Hydrophobic/Hydrophilic balance
Interactions with microbial extracelluar
membranes
Non Covalent intermolecular interactions (e.g. Van 
der Waal’s, π‐π stacking) 
Interaction with intracellular targets/processes 
(DNA, RNA, enzymes, protein synthesis). 
Binds to DNA, lipopolysaccharide to prevent pro‐
inflammatory response = immunomodulatory 
Ability of peptide to form hydrogen bonds with 
each other and with water
McCloskey A.P., Gilmore, B.F., Laverty, G. (2014) Evolution of Antimicrobial 
Peptides to Self-Assembled Peptides for Biomaterial Applications. Pathogens. 
3(4); 791-821.
Advantages of Ultrashort Peptides
• Successful in producing a series peptide sequences of that 
self-assemble to form hydrogels or nanotubes in response to 
physiological stimuli
• Ultrashort  peptides (< 7 amino acids) → More cost effective
→ Upscale by Pharmaceutical Industry → Increased 
translational potential → Patient benefit
• Numerous advantages over current synthetic materials 
including:
• Increased chemical versatility 
• Minimal immunogenicity and enhanced biocompatibility
• Tunable biodegradability 
• Tailored self-assembly/pharmacological properties (e.g. 
antimicrobial) in response to stimuli 
Biofunctional Nanomaterials Utilising the 
Building Blocks of Life!
Wound healing 
Stem Cells/Regenerative 
medicine
Infection and Medical 
Devices  
Drug Delivery (Blood brain barrier, cancer, Gram-
negative bacteria, HIV, in situ forming implants ) 
Peptide Hydrogel Nanomaterials
Peptide Hydrogels 
Self-assembled Ultrashort Peptide Gels
• 2013 Research Placement Prof. Bing Xu Lab, School of Chemistry, Brandeis, 
Waltham, Boston
• Successful in producing a series of ultrashort  peptides (< 7 amino acids) that 
self-assembled at physiological pH
• (X1-FF-X2)
• More cost effective
• Hydrophobicity provided by inclusion of a naphthalene (Nap) grouping (at X1 
position) and varying quantity of phenylalanine in primary structure
O
NH
O
NH
O
OH
NapFF 
structure
Ultrashort Cationic Variants: Primary Structures
• Charge: Inclusion of cationic amino acids
– 1) Lysine 
– 2) Ornithine 
– 3) epsilon (ε) Lysine
• Minimum of 2 charged units required for antimicrobial and antibiofilm activity
• Primary amine group provides cationic charge
• Cationic amino acids vary by number of methylene units on R-group
-Laverty, G., McCloskey A.P., Gilmore, B.F., Jones, D.S., Zhou, J., Xu, B (2014).  
Ultrashort Cationic Naphthalene derived Self-assembled Peptides as Antimicrobial 
Nanomaterials. Biomacromolecules; 15: 3429−3439.
NapFFKK: Fungal infections
• Albadr,A., Gilmore,S.M., Porter,S.L, Thakur,R., Laverty,G.* (2018). Ultrashort self‐assembling peptide hydrogel for the 
treatment of fungal infections. Gels. 4: 48.
Fungal viability counts (Log10 CFU/mL) of Aspergillus niger CABI 017454 after 24 h exposure
Fmoc variants antibiofilm
McCloskey,A.P., Draper,E.R., Gilmore, B.F., Laverty,G.* (2017). Ultrashort self‐assembling Fmoc‐peptide 
gelators for anti‐infective biomaterial applications. Journal of Peptide Science. 23 (2): 131–140.
Percentage reduction in viability of 24 hour E. coli (ATCC 11303) 
biofilm following 24 hour exposure to Fmoc‐peptides. 
Percentage cell viability of NCTC clone 929 (ATCC CCL 1) 
cells after 24 hour exposure to varying concentrations of 
Fmoc‐peptides. 
Multifunctional NSAID-peptide hydrogels for the 
treatment of chronic wounds
• Chronic wounds: unable to heal fully or respond to 
treatment within 4 to 12 weeks. E.g. pressure wounds, 
diabetic ulcers, burn/surgical wounds.
• Latest UK estimates (2005-06), reported an incidence 
of 575,600 patients annually costing the NHS between 
£2.3 and 3.1billion, 3% of yearly healthcare 
expenditure. 
• Differ from acute wounds in that they are associated 
with prolonged inflammation that prevents healing 
fully: Non steroidal anti-inflammatory drugs (NSAIDs) 
showing benefit.
• Optimal multifunctional peptide: hydrogelating, 
biocompatible, antimicrobial, anti-inflammatory, pro-
angiogenic
Prevention better than cure!!
a)
NFκBIκB
IKKα/IKKβ
kinases
NSAID (PO3)−
c)
IL-6
IL-8
IL-10
↓ inflammation
b)
g)
M
R
S
A
P
.aeruginosa
f) e)
TLRs NFκB ↓ inflammation
NSAID-peptide
COX-2
Selective Cox-2 
inhibition:
↓ scar-tissue formation
d)
DNA
LPS
Nanofibrous scaffold
supports cell growth 
 subcutaneous 
fibroblast 
migration
 keratinocyte migration
 recruitment & activation of VEGF, 
FGF2, HGF growth factors: 
angiogenesis
TNF-α
 VEGF, FGF2, HGF growth factors:
NFκB
Multifunctional NSAID-peptide hydrogels: Design
Naproxen
Ibuprofen
Indomethacin
McCloskey,A.P., Gilmore,S.M., Zhou, J., Draper,E.R., Porter,S., Gilmore, B.F., Xu, B., Laverty,G.* (2016). Self-assembling ultrashort NSAID-Peptide nanosponges: 
multifunctional antimicrobial and anti-inflammatory materials. RSC Advances. 6: 114738-114749.
Optimal multifunctional peptide: 
• Hydrogelating ✓
• Biocompatible ✓
• Antimicrobial ✓
• Anti-inflammatory/immunomodulatory 
• selective COX-2 inhibition     ✓
• inhibit NFκB
• inhibit toll-like receptors by binding to biomolecules (e.g. 
DNA, bacterial LPS)
NSAID
Cationic 
dilysine
Heparin-
mimetic motif
• Pro-angiogenic (heparin mimetic motif)
Multifunctional NSAID-peptide hydrogels: 
Hydrogelating, Biocompatible 
Oscillatory frequency sweep 2% w/v NSAID-peptides. 
Key: black triangle: Gʹ IbuFFKK, white triangle: Gʺ 
IbuFFKK black circle: Gʹ IndFFKK, white circle: Gʺ 
IndFFKK, black square: Gʹ NpxFFKK, white square: Gʺ 
NpxFFKK.
Data relating to L-isomers of 2%w/v peptide. a) Npx-
FFKK-OH hydrogel. b) TEM showing Npx-FFKK-OH 
nanofibres. c) LIVE/DEAD assay, 500µM Npx-FFKK-OH 
with NCTC929 fibroblasts. 
McCloskey,A.P., Gilmore,S.M., Zhou, J., Draper,E.R., Porter,S., 
Gilmore, B.F., Xu, B., Laverty,G.* (2016). Self-assembling 
ultrashort NSAID-Peptide nanosponges: multifunctional 
antimicrobial and anti-inflammatory materials. RSC Advances. 6: 
114738-114749.
Multifunctional NSAID-peptide hydrogels: 
Biocompatible & COX-2 selective (anti-inflammatory)
Cell compatibility and COX inhibition of L-isomers of X-FFKK-OH peptides. Ibuprofen (Ibu), indomethacin (Ind) and Npx conjugated at X. a) >90% cell viability, NCTC929 fibroblasts, 24 hour 
exposure (alamar blue assay). Key: striped:IbuFFKK, white:IndFFKK, grey:NpxFFKK, ns:no significant difference compared to negative PBS control. b) IC50 NSAID-peptide and NSAIDs only, 
inhibition of COX-1 (black column) and COX-2 (white column). Selectivity (S)=COX-1:COX-2 ratio of IC50 values. Addition of FFKK-OH to NSAIDs increases IC50 values relative to NSAID only but 
significant inhibition is maintained within the µM range. NSAID-peptides possess increased COX-2 selectivity compared to NSAID only, which is promising for chronic wound therapy. COX-2 
selectivity highest for NpxFFKK-OH (S=2.78) therefore it is the most promising NSAID-peptide for reducing scar tissue formation in chronic wounds.
Multifunctional NSAID-peptide hydrogels: Anti-
biofilm/Antimicrobial
Bactericidal activity of NSAID-FFKK-OH. a) NpxFFKK-OH (2-0.5%w/v) shows >90% in 24 hour biofilms of S.aureus ATCC25923 (black column), 
S.epidermidis ATCC35984 (grey), E.coli ATCC11303 (striped) and P.aeruginosa PAO1 (white) after 24 hours (alamar blue assay). b) Log10 reduction in 
S.aureus viable count after 24 hours, NSAID-peptides (2-0.5%w/v). Key: striped column: IbuFFKK-OH, white: IndFFKK-OH, grey: NpxFFKK-OH, dotted 
line: PBS control. At least a 3 log10CFU/mL (99.9%) reduction in bacteria, employed as a threshold for efficacy was observed for all NSAID-peptides at 
concentrations ≥0.5% w/v compared to PBS control. A similar trend was demonstrated for NSAID-peptides against S.epidermidis, E.coli and 
P.aeruginosa. 
Biofilms Mixture of biofilms, surface attached and liquid (planktonic bacteria)
Peptide Nanotubes
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Tuesday 3rd September ~9.25am: Optimising phenylalanine‐
phenylalanine peptide nanotubes to demonstrate selective antibiofilm
activity 
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